Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Prabakaran A, Mukta Agrawal, Mithun Rajendra Dethe, Hafiz Ahmed, Awesh Yadav, Umesh Gupta & Amit Alexander. (2022) Nose-to-brain drug delivery for the treatment of Alzheimer’s disease: current advancements and challenges. Expert Opinion on Drug Delivery 19:1, pages 87-102.
Read now
Read now
Ruchira Raychaudhuri, Abhjieet Pandey, Aswathi Hegde, Shaik Mohammad Abdul Fayaz, Dinesh Kumar Chellappan, Kamal Dua & Srinivas Mutalik. (2020) Factors affecting the morphology of some organic and inorganic nanostructures for drug delivery: characterization, modifications, and toxicological perspectives. Expert Opinion on Drug Delivery 17:12, pages 1737-1765.
Read now
Read now
Ghasem Ghalamfarsa, Mohammad Hojjat-Farsangi, Mousa Mohammadnia-Afrouzi, Enayat Anvari, Shohreh Farhadi, Mehdi Yousefi & Farhad Jadidi-Niaragh. (2016) Application of nanomedicine for crossing the blood–brain barrier: Theranostic opportunities in multiple sclerosis. Journal of Immunotoxicology 13:5, pages 603-619.
Read now
Read now
Yongjun Jiang, Yun Li & Xinfeng Liu. (2015) Intranasal delivery: circumventing the iron curtain to treat neurological disorders. Expert Opinion on Drug Delivery 12:11, pages 1717-1725.
Read now
Read now
Articles from other publishers (19)
Sunita Dahiya & Rajiv Dahiya. 2023. Nasal Drug Delivery. Nasal Drug Delivery
141
168
.
Tejas Girish Agnihotri, Govinda Shivaji Jadhav, Bichismita Sahu & Aakanchha Jain. (2022) Recent trends of bioconjugated nanomedicines through nose-to-brain delivery for neurological disorders. Drug Delivery and Translational Research 12:12, pages 3104-3120.
Crossref
Crossref
Jeehye Maeng & Kyunglim Lee. (2022) Systemic and brain delivery of antidiabetic peptides through nasal administration using cell-penetrating peptides. Frontiers in Pharmacology 13.
Crossref
Crossref
Pranav Shah, Manisha Lalan & Kalyani Barve. (2022) Intranasal delivery: An attractive route for the administration of nucleic acid based therapeutics for CNS disorders. Frontiers in Pharmacology 13.
Crossref
Crossref
Mohammad Yaghoub Abdollahzadeh Jamalabadi & Jinxiang Xi. (2022) Olfactory Drug Aerosol Delivery with Acoustic Radiation. Biomedicines 10:6, pages 1347.
Crossref
Crossref
Honey Goel, Vinni Kalra, Sant Kumar Verma, Sunil Kumar Dubey & Ashok Kumar Tiwary. (2022) Convolutions in the rendition of nose to brain therapeutics from bench to bedside: Feats & fallacies. Journal of Controlled Release 341, pages 782-811.
Crossref
Crossref
Pearl Dighe. 2022. Nanocarriers for Drug-Targeting Brain Tumors. Nanocarriers for Drug-Targeting Brain Tumors
205
233
.
Rahul Shukla, Ashish Kumar & S.J.S. Flora. 2021. Direct Nose-to-Brain Drug Delivery. Direct Nose-to-Brain Drug Delivery
73
91
.
Mei Mei Tian & Reinhard Gabathuler. 2021. Nanomedicines for Brain Drug Delivery. Nanomedicines for Brain Drug Delivery
119
147
.
Yujun Zeng, Zhiqian Li, Hongyan Zhu, Zhongwei Gu, Hu Zhang & Kui Luo. (2020) Recent Advances in Nanomedicines for Multiple Sclerosis Therapy. ACS Applied Bio Materials 3:10, pages 6571-6597.
Crossref
Crossref
Mahira Zeeshan, Mahwash Mukhtar, Qurat Ul Ain, Salman Khan & Hussain Ali. 2020. Pharmaceutical Formulation Design - Recent Practices. Pharmaceutical Formulation Design - Recent Practices.
Eleni Samaridou, Hannah Walgrave, Evgenia Salta, David Moreira Álvarez, Vanessa Castro-López, Mabel Loza & Maria José Alonso. (2020) Nose-to-brain delivery of enveloped RNA - cell permeating peptide nanocomplexes for the treatment of neurodegenerative diseases. Biomaterials 230, pages 119657.
Crossref
Crossref
Toyofumi SUZUKI, Naoto SUZUKI & Takanori KANAZAWA. (2020) Transport Mechanism in the Nose-to-Brain Drug Delivery and Role of Nanosystems鼻から脳への薬物送達における輸送機構とナノシステムの役割. Oleoscience 20:2, pages 61-69.
Crossref
Crossref
Magisetty Obulesu. 2020. Parkinson's Disease Therapeutics. Parkinson's Disease Therapeutics
89
101
.
Takanori Kanazawa, Takumi Kurano, Hisako Ibaraki, Yuuki Takashima, Toyofumi Suzuki & Yasuo Seta. (2019) Therapeutic Effects in a Transient Middle Cerebral Artery Occlusion Rat Model by Nose-To-Brain Delivery of Anti-TNF-Alpha siRNA with Cell-Penetrating Peptide-Modified Polymer Micelles. Pharmaceutics 11:9, pages 478.
Crossref
Crossref
Florence CourtensJean-Louis DemangeatMourad Benabdallah. (2018) Could the Olfactory System Be a Target for Homeopathic Remedies as Nanomedicines?. The Journal of Alternative and Complementary Medicine 24:11, pages 1032-1038.
Crossref
Crossref
Takanori Kanazawa. (2018) Development of Noninvasive Drug Delivery Systems to the Brain for the Treatment of Brain/Central Nervous System Diseases非侵襲的な脳内への薬物送達技術の開発と脳神経疾患治療への応用. YAKUGAKU ZASSHI 138:4, pages 443-450.
Crossref
Crossref
Fabio Sonvico, Adryana Clementino, Francesca Buttini, Gaia Colombo, Silvia Pescina, Silvia Stanisçuaski Guterres, Adriana Raffin Pohlmann & Sara Nicoli. (2018) Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting. Pharmaceutics 10:1, pages 34.
Crossref
Crossref
Antonio Topete, Silvia Barbosa & Pablo Taboada. (2015) Intelligent micellar polymeric nanocarriers for therapeutics and diagnosis. Journal of Applied Polymer Science 132:41, pages n/a-n/a.
Crossref
Crossref